Find therapies in clinical trials near you – page 68

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections

Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis

Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis

Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma